For all media enquiries please contact Jennifer Durante, Head of Communications & Fundraising Email media@melanoma.org.au Phone 0412 798 990.
National targeted melanoma screening program is step closer
Read more about 'Skin Checks for Melanoma in Australia Position Statement’, led by MIA in collaboration with expert colleagues across Australia.
AIS releases Sun Safe guidelines for sport
The Australian Institute of Sport (AIS) has joined forces with Paddle Australia and the nation’s peak expert bodies on skin cancer and UV radiation - including Melanoma Institute Australia - to ensure everyone involved in sport is sun safe this summer.
MIA establishes MIA Women in Leadership Investment Fund
This important initiative will enable all MIA employees identifying as female to further develop and accelerate their leadership skills training.
Our passionate community fundraisers
Read more about the inspiring stories behind the dedication and generosity of our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
Dr Jordan Conway
Meet Dr Jordan Conway, whose crucial research focuses on melanoma metastases in the liver, and neoadjuvant immunotherapy.
Xinyu (Catherine) Bai
Meet Catherine, a PhD student and researcher at MIA. Catherine's current research focus is "Single Cell Spatial Features of In-Transit Melanoma Associated With Patient Outcomes To Immunotherapy".
MIA’s Co-Medical Directors named 2024 Australians of the Year
We are so proud of our MIA Co-Medical Directors, Prof Georgina Long AO and Prof Richard Scolyer AO, jointly named 2024 Australians of the Year.
PBS listing is life-changing news
The federal government has announced a new immunotherapy treatment for advanced melanoma patients has been added to PBS, significantly reducing the cost of the life-saving treatment.
Gratitude for our Community Fundraisers!
Read more about the inspiring stories behind the amazing efforts, dedication and generosity of our Community Fundraisers. Find out how you can fundraise to support melanoma research.
Four MIA researchers receive Tour de Cure grants
We are delighted to have been successful in receiving four research grants recently awarded by Tour de Cure Australia.
NADINA trial “will shape medicine in 2024”
A clinical trial, developed by MIA researchers in collaboration with international colleagues, has been named by prestigious journal Nature Medicine as one of 11 clinical trials likely to have the most impact on global medicine in the year ahead.
Co-Medical Directors named in list of “News Makers of 2023”
Prof Georgina Long and Prof Richard Scolyer have been named in Top 52 News Makers for 2023 by the Sydney Morning Herald 'Good Weekend' magazine.
Jimmyanich says:
Mary Van Wyk says:
Josias Pimentel says: